Abstract
We evaluated the use of cross-linked hyaluronic acid (CLHA) in the anterior segment of the rabbit's eye. Subconjunctival injection of less than 0.1ml of CLHA was well tolerated. Intracameral injection containing more than 0.05 ml of CLHA produced severe inflammatory reaction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Balazs EA, Hultsch E: Replacement of the vitreous with hyaluronic acid, collagen and other polymers, in Irvine A, O'Malley C (eds): Advances in Vitreous Surgery. Springfield, II, Charles C. Thomas: pp 609–611, 1976
Miller D: Healon. Ann Ophthalmol 13: 781, 1981
Pape LG: Intracapsular and extracapsular technique of lens implantation with Healon®. Am Intraocular Implant Soc J 6: 340, 1980
Pape LG, Balazs EA: The use of sodium hyaluronate (Healon) in human anterior segment surgery. Ophthalmology 87: 699, 1980
Polack FM, Demong T, Santaella H: Sodium hyaluronate (Healon®) in intracapsular cataract extraction with insertion of anterior chamber intraocular lenses. Presented at the meeting of the American Academy of Ophthalmology, November 1980, Chicago, IL, USA
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peyman, G.A., Kao, G.W. Use of crossed-linked hyaluronic acid in the anterior segment. Int Ophthalmol 10, 133–141 (1987). https://doi.org/10.1007/BF00139338
Issue Date:
DOI: https://doi.org/10.1007/BF00139338